Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial
<p><strong>Background:</strong> Recent basic and clinical evidence suggests amiloride may be neuroprotective in multiple sclerosis (MS) through the blockade of the acid sensing ion channel.</p> <p><strong>Objective:</strong> To examine the neuroprotective ef...
Main Authors: | McKee, J, Cottriall, C, Elston, J, Epps, S, Evangelou, N, Gerry, S, Kennard, C, Kong, Y, Koelewyn, A, Kueker, W, Leite, M, Palace, J, Craner, M |
---|---|
Format: | Journal article |
Published: |
SAGE Publications
2017
|
Similar Items
-
AMILORIDE CLINICAL TRIAL IN OPTIC NEURITIS: TRIAL PARADIGM
by: McKee, J, et al.
Published: (2014) -
A phase II randomised controlled trial of amiloride as a neuroprotective treatment in optic neuritis – studying in vivo neurodegeneration, neuroprotection and cortical plasticity after an inflammatory insult to the visual system
by: McKee, J
Published: (2017) -
Correlation of Retinal Nerve Fibre Layer Thickness in Optical Coherence Tomography with Visual Outcome in Optic Neuritis
by: C Usha, et al.
Published: (2024-06-01) -
Prospective Study on Retinal Nerve Fibre Layer Thickness Changes in Isolated Unilateral Retrobulbar Optic Neuritis
by: Gordon S. K. Yau, et al.
Published: (2013-01-01) -
AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
by: Arun, T, et al.
Published: (2012)